טוען...
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
Women with polycystic ovary syndrome (PCOS) have an adverse metabolic profile with an increased risk of prediabetes and type 2 diabetes (T2DM); however, it is unclear if PCOS is associated with increased cardiovascular events in later years independent of the presence of T2DM. Many therapies have be...
שמור ב:
| הוצא לאור ב: | Ther Adv Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378434/ https://ncbi.nlm.nih.gov/pubmed/30800265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018818805674 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|